How to choose a healthcare market research company

Audience access

Everything else in healthcare research is downstream of whether a firm can reach the right people. Ask how many verified physicians, payers, procurement leaders and executives they can reach in your target specialties and markets, then make it concrete by naming your hardest profile. A partner who says a community-based interventional cardiologist in a tier-2 city will take three weeks is more useful than one who says everything is available immediately.

Distinguish between owned networks, partner networks and open panels. All three are legitimate, but they behave differently: an owned network gives traceability and repeat access, partner networks extend geography at the cost of direct oversight, and online panels deliver volume in common specialties but thin out sharply in rare ones. Ask which of the three your sample will actually come from.

Recruitment and verification

The most common quality failure in healthcare research is not weak analysis, it is a respondent who is not who the screener says they are. Ask how credentials are verified — registration or licence checks, institutional email, employment history, publication record — and how often a given individual can be re-used across studies. Over-surveyed respondents learn to pass screeners, which quietly biases everything downstream.

Ask about in-field quality control too: how out-of-scope respondents are terminated, whether open-ended answers are reviewed for copy-paste and nonsense, how straight-lining and speeding are handled in quantitative work, and whether the moderator on a qualitative project is the person who wrote the guide. Strong firms volunteer these controls; weaker ones describe them only when pressed.

Compliance and data protection

Treat compliance as part of the methodology review rather than a legal formality, because it shapes what the research may ask and what you may do with the output. Confirm the firm works to the EphMRA, BHBIA and Insights Association codes, keeps research strictly non-promotional and avoids off-label probing, and operates a documented adverse event and product complaint process with an agreed reporting window to your pharmacovigilance team.

On data, check the lawful basis for processing, consent wording, pseudonymisation, where recordings and transcripts are hosted, who internally can access them, and the retention and deletion schedule. In India, DPDP Act obligations sit alongside CDSCO rules and the UCPMP code; in the EU and US, GDPR and HIPAA set the terms. A firm that cannot put these in writing will eventually hand you a study your own compliance team blocks.

Speed, coverage and local fieldwork

Speed means two separate things: how fast the first expert conversation can happen, and how fast a full study can go to field. Expert matching inside 24 to 48 hours is a reasonable expectation in common specialties; a qualitative wave realistically needs two to four weeks of fieldwork and a quantitative study four to eight. Be sceptical of a promise that collapses either without naming what is being traded away.

For coverage, ask whether fieldwork outside the firm's home market runs through local partners or through remote online panels only. Local moderation matters disproportionately in healthcare: regional-language interviews, in-clinic access and knowledge of how a given health system actually works are not things a translated questionnaire reproduces.

Analytical depth and senior involvement

The gap between a competent fieldwork house and a research partner is analysis. Ask who will design the instrument, who will moderate, who will write the report, and how much of that person's time is actually in the quote. Pitch teams are routinely more senior than delivery teams, and naming individuals in the statement of work is the simplest way to close that gap.

Then read a redacted deliverable backwards. A good report ends with a recommendation, states confidence and limitations honestly, and separates what respondents said from what the analyst concluded. If the final pages only summarise the preceding charts, you are buying description rather than judgement.

Commercials and contracting

Ask for a cost breakdown that separates respondent honoraria, recruitment effort, moderation, analysis and reporting. Honoraria and recruitment usually dominate, which means the hardest audience in your sample sets the budget — and that a cheaper quote often signals an easier sample rather than a better price. Clarify what happens if feasibility turns out worse than estimated: who absorbs the extra recruitment cost, and when scope is renegotiated.

In the contract, pin down ownership of data, transcripts and recordings, subcontracting and offshoring disclosure, confidentiality in both directions, and the right to re-contact respondents for a follow-up wave. Multi-wave trackers should fix the methodology in writing, because a mid-programme change to the sample definition destroys comparability between waves.

Red flags

Some signals are reliably bad. A firm that reports no feasibility constraints on a genuinely rare audience is either not checking or not telling. A proposal that leads with sample size rather than with the decision has not read the brief. A refusal to show any redacted deliverable usually means there is nothing worth showing.

• No named moderator or analyst in the statement of work.
• Vague answers on how respondent credentials are verified, or on respondent re-use.
• No documented adverse event and product complaint process.
• Unwillingness to put data retention, deletion and hosting terms in writing.
• Quantitative quotes with no mention of data-quality checks or terminated interviews.
• Claimed coverage of every market with no local partners and no local-language moderation.
• A timeline that does not move when you make the audience harder.

A scoring sheet you can reuse

Weight the criteria before you see the proposals, so the evaluation is not retrofitted to a favourite. A weighted score across six dimensions is usually enough, and it makes the trade-off explicit when the cheapest bid is also the weakest on access.

• Audience access and feasibility realism — the heaviest weight in almost every brief.
• Recruitment sourcing and credential verification.
• Compliance, consent and data handling, in writing.
• Design and analytical depth, evidenced by a redacted deliverable.
• Named senior involvement and continuity from pitch to delivery.
• Total cost, scope-change terms and contractual rights over the data.